Newer hormonal pharmacotherapies for heart failure

@article{Yandrapalli2018NewerHP,
  title={Newer hormonal pharmacotherapies for heart failure},
  author={Srikanth Yandrapalli and George P Jolly and Medha Biswas and Y. Rochlani and P. Harikrishnan and W. Aronow and G. Lanier},
  journal={Expert Review of Endocrinology \& Metabolism},
  year={2018},
  volume={13},
  pages={35 - 49}
}
ABSTRACT Introduction: Heart failure (HF) is characterized by maladaptive neurohormonal activation of the cardiovascular and renal systems resulting in circulatory inadequacy and frequent acute exacerbations. The increasing burden of HF prompted investigation of underlying pathophysiological mechanisms and the design of pharmacotherapeutics that would target these pathways. Areas covered: A MEDLINE search for relevant original investigations and review articles of newer hormonal drugs for HF… Expand
Small molecules for modulating the localisation of the water channel aquaporin-2—disease relevance and perspectives for targeting local cAMP signalling

References

SHOWING 1-10 OF 127 REFERENCES
Advances in chemical pharmacotherapy for managing acute decompensated heart failure
Heart failure as a multiple hormonal deficiency syndrome.
  • L. Saccá
  • Medicine
  • Circulation. Heart failure
  • 2009
Endothelin and Heart Failure
...
1
2
3
4
5
...